mrna news - Search News

GSK, mRNA

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the market for cancer, influenza and more.

Reuters on MSN · 6d

British drugmaker GSK moves mRNA flu vaccine to late-stage trials

(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, and said it would now progress to late-stage clinical development.

Science Daily · 5d

Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers. The investigational mRNA cancer immunotherapy is targeted for patients with lung cancer,

Detroit News · 7d

GSK says mRNA flu shot shows promise in boost for pipeline

GSK Plc’s experimental mRNA flu vaccine showed a positive immune response against two key types of flu viruses in a mid-stage trial.

Seeking Alpha on MSN · 7d

GSK, CureVac mRNA flu shot reaches late-stage studies

GSK (NYSE:GSK) on Thursday announced its decision to advance its messenger-RNA-based flu vaccine candidate developed with CureVac (NASDAQ:CVAC) into late-stage development following a positive Phase 2 readout.

5don MSN

Florida discourages use of mRNA Covid vaccines in older adults

Even as the Covid wave in Florida continues, Gov. Ron DeSantis’ administration is once again advising against the mRNA ...

Fact Check: German study did not find mRNA shots ‘eat away’ at children’s immune systems

A German study published in July 2024 did not find that mRNA COVID-19 vaccines damaged children’s immune systems, contrary to ...

BizPac Review5d

Free State of Florida advises against ANY use of mRNA COVID-19 vaccine

Based on the high rate of global immunity and currently available data, the State Surgeon General advises against the use..." ...

15h

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRNA

New York, New York-- (Newsfile Corp. - September 18, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) between January 18 ...

emjreviews.com4d

COVID-19 mRNA Vaccination Safe for Patients with Sickle Cell Disease

Did you know that the COVID-19 mRNA vaccination is safe and beneficial for children and adults with sickle cell disease?

5don MSN

Contradicting experts, Fla. health chief advises seniors to avoid mRNA COVID-19 boosters

Florida health officials are raising alarms about the safety of the newest versions of mRNA COVID-19 vaccines, advising ...

News Medical on MSN8d

COVID-19 mRNA vaccine linked to myocardial scarring in adolescents and young adults

The study investigates COVID-19 vaccine-related myocarditis in adolescents, revealing clinical characteristics and risks of ...

7don MSN

Primrose Bio Partners with Polish Firm to Develop Products That Lead to mRNA Therapies

Primrose Bio, a San Diego biotech company, has begun a partnership to jointly develop and market products for mRNA medicines.

GlobalData on MSN6d

ESMO 2024: Moderna’s mRNA solid tumour vaccine shows early promise

Moderna's mRNA-4359 has shown early signs of efficacy, activating key proteins to trigger an immune response for cancer ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics